Publications by authors named "Hobyung Chung"

Claim this Profile
E
Effect of Computer-Aided Detection During Colonoscopy on Adenoma Detection Rate in a Community Hospital Setting: Randomized Controlled Trial.
Yohei Yabuuchi, Kazuya Hosotani, Yoshiki Morihisa, Yukie Fujio, Daisuke Oshikawa, Hobyung Chung

Dig Endosc· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Gastric Neuroendocrine Tumors Associated with Long-term Use of a Proton Pump Inhibitor and a Potassium-competitive Acid Blocker.
Soichiro Nagao, Yohei Yabuuchi, Kosuke Tanaka, Yoshiki Morihisa, Takuya Kobayashi, Chung Hobyung

Intern Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoimmune hepatitis and primary sclerosing cholangitis after direct-acting antiviral treatment for hepatitis C virus: A case report.
Yoshiki Morihisa, Hobyung Chung, Shuichiro Towatari, Daisuke Yamashita, Tetsuro Inokuma

World J Hepatol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Factors of Proteinuria in Patients with Hepatocellular Carcinoma Receiving Lenvatinib.
Hiroaki Ikesue, Haruna Yamamoto, Masaki Hirabatake, Tohru Hashida, Hobyung Chung

Biol Pharm Bull· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoimmune hepatitis and IgG4-related disease.
Kosuke Minaga, Tomohiro Watanabe, Hobyung Chung, Masatoshi Kudo

World J Gastroenterol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of pharmaceutical intervention in direct-acting antiviral agents for hepatitis C virus infected patients in an ambulatory setting: a retrospective analysis.
Haruna Yamamoto, Hiroaki Ikesue, Mai Ikemura, Rieko Miura, Kazumi Fujita, Hobyung Chung

J Pharm Health Care Sci· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum IFN-λ3 Levels Correlate with Serum Hepatitis C Virus RNA Levels in Symptomatic Patients with Acute Hepatitis C.
Susumu Imoto, Soo Ryang Kim, Keisuke Amano, Etsuko Iio, Seitetsu Yoon, Hobyung Chung

Dig Dis· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD68-Positive Cells in Hepatic Angiomyolipoma.
Hitoshi Tochio, Eriko Tamaki, Yukihiro Imai, Nobuhiro Iwasaki, Kazushi Minowa, Hobyung Chung

Oncology· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II Study of Sorafenib in Combination with Hepatic Arterial Infusion Chemotherapy Using Low-Dose Cisplatin and 5-Fluorouracil.
Kazuomi Ueshima, Masatoshi Kudo, Masatoshi Tanaka, Takashi Kumada, Hobyung Chung

Liver Cancer· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case of primary hepatic gastrinoma: Diagnostic usefulness of the selective arterial calcium injection test.
Satoshi Ogawa, Masaya Wada, Masashi Fukushima, Naoto Shimeno, Satoko Inoue, Hobyung Chung

Hepatol Res· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes and Prognostic Factors in Patients with Spontaneously Ruptured Hepatocellular Carcinoma.
Tomonori Matsumoto, Hobyung Chung, Yoshiki Suginoshita, Kyo Ito, Tetsuro Inokuma

Hepatogastroenterology· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A case of jejunal ectopic pancreatic cancer: the diagnostic usefulness of MRI].
Satoshi Ogawa, Masashi Fukushima, Hobyung Chung, Mikio Fujita, Yoshiki Suginoshita

Nihon Shokakibyo Gakkai Zasshi· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoimmune hepatitis and immunoglobulin G4-associated autoimmune hepatitis.
Norihisa Yada, Masatoshi Kudo, Hobyung Chung, Tomohiro Watanabe

Dig Dis· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The gross classification of hepatocellular carcinoma: usefulness of contrast-enhanced US.
Kinuyo Hatanaka, Yasunori Minami, Masatoshi Kudo, Tatsuo Inoue, Hobyung Chung

J Clin Ultrasound· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT.
Tatsuo Inoue, Masatoshi Kudo, Mina Komuta, Sosuke Hayaishi, Taisuke Ueda, Hobyung Chung

J Gastroenterol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of interleukin-28B and hepatitis C genotype 1 with a high viral load and response to pegylated interferon plus ribavirin therapy.
Masahiro Takita, Satoru Hagiwara, Tadaaki Arizumi, Sousuke Hayaishi, Taisuke Ueda, Hobyung Chung

Digestion· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of c-Jun N-terminal kinase in non-cancerous liver tissue predicts a high risk of recurrence after hepatic resection for hepatocellular carcinoma.
Satoru Hagiwara, Masatoshi Kudo, Hobyung Chung, Kazuomi Ueshima, Tatsuo Inoue

Hepatol Res· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usefulness of combination of imaging modalities in the diagnosis of hepatocellular carcinoma using Sonazoid®-enhanced ultrasound, gadolinium diethylene-triamine-pentaacetic acid-enhanced magnetic resonance imaging, and contrast-enhanced computed tomography.
Alshimaa Alaboudy, Tatsuo Inoue, Kinuyo Hatanaka, Hobyung Chung, Tomoko Hyodo

Oncology· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Des-γ-carboxyprothrombin may be a promising biomarker to determine the therapeutic efficacy of sorafenib for hepatocellular carcinoma.
Kazuomi Ueshima, Masatoshi Kudo, Masahiro Takita, Tomoyuki Nagai, Chie Tatsumi, Hobyung Chung

Dig Dis· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral branched-chain amino acid granules reduce the incidence of hepatocellular carcinoma and improve event-free survival in patients with liver cirrhosis.
Sosuke Hayaishi, Hobyung Chung, Masatoshi Kudo, Emi Ishikawa, Masahiro Takita

Dig Dis· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Effects of interferon treatment on recurrence and survival after curative treatment of hepatitis C virus-related hepatocellular carcinoma].
Taisuke Ueda, Hobyung Chung, Masatoshi Kudo

Nihon Rinsho· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cancer stem cell marker CD133 is a predictor of the effectiveness of S1+ pegylated interferon α-2b therapy against advanced hepatocellular carcinoma.
Satoru Hagiwara, Masatoshi Kudo, Kazuomi Ueshima, Hobyung Chung, Mami Yamaguchi

J Gastroenterol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C virus core protein induces homotolerance and cross-tolerance to Toll-like receptor ligands by activation of Toll-like receptor 2.
Hobyung Chung, Tomohiro Watanabe, Masatoshi Kudo, Tsutomu Chiba

J Infect Dis· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiofrequency ablation for hepatocellular carcinoma: assistant techniques for difficult cases.
Tatsuo Inoue, Yasunori Minami, Hobyung Chung, Sousuke Hayaishi, Taisuke Ueda

Oncology· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic arterial infusion chemotherapy using low-dose 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma.
Kazuomi Ueshima, Masatoshi Kudo, Masahiro Takita, Tomoyuki Nagai, Chie Tatsumi, Hobyung Chung

Oncology· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis